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Abstract
Few Orthopaedics and Traumatology journals from Latin America and Spain are indexed in major databases; controlled clinical 
trials published in these journals cannot be exhaustively retrieved using electronic literature searches. We aimed to identify, 
describe and assess the quality of controlled clinical trials published in Orthopaedics and Traumatology journals from Latin 
America and Spain through handsearching and evidence mapping methods. We identified controlled clinical trials published in 
eligible Orthopaedics/Traumatology journals in Spanish until July 2017 by handsearching. Data were extracted for controlled 
clinical trials main characteristics and the Cochrane risk of bias tool was used to assess the controlled clinical trials methodological 
quality. In addition, we mapped the main findings of these trials. As a result, we assessed 5631 references in 29 eligible journals 
of which 57 were controlled clinical trials (1.0%). Controlled clinical trials were published between 1995 and 2017 at a rate 
of 2.5 per year. Journals from Spain and Mexico published around 63% of the controlled clinical trials identified. The median 
sample size of patients enrolled was 60 (range = 30–300 participants). About conditions assessed, 38.5% of controlled clinical 
trials assessed issues related to knee conditions, 15.7% about hip and 10.5% about trauma or spine. The risk of bias domains 
most affected was selective reporting bias and random sequence generation. In addition, only two and seven trials had low risk 
of bias in all items related to participant/personnel and outcome assessment blindings, respectively. More than 40% of studies 
did not report differences on benefits/harms between the interventions assessed. As a conclusion, the number of controlled 
clinical trials published in Orthopaedics/Traumatology journals from Latin America and Spain is low. These controlled clinical 
trials had important methodological shortcomings and were judged as unclear or high risk of bias. These trials are now available 
in CENTRAL for their potential inclusion in systematic reviews and other documents of synthesis.
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Introduction
The global burden of musculoskeletal conditions, such as hip 
fractures, osteoporosis and anterior cruciate ligament inju-
ries, is related to high morbidity and mortality, as well as to 
an increase in the use of resources in worldwide healthcare 
systems.1–6 There is a growing need of high-quality evidence 
in this field in order to inform patients, healthcare profes-
sionals and policymakers about the best alternatives for the 
management of bone and joint–related injuries and 
disorders.7
Controlled clinical trials (CCTs) continue to be the cor-
nerstone of evidence-based medicine. High-quality CCTs 
provide the best evidence of the effectiveness and safety of 
interventions in healthcare by implementing methodology 
aimed at diminishing confounding and other associated 
biases.8 CCTs in Orthopaedics and Traumatology are scarce 
and have been widely criticized because of their lack of 
internal and external validity as well as deficiencies in 
reporting.9–13 Bhandari et al.14 assessed CCTs published in 
The Journal of Bone and Joint Surgery, finding that over 
50% had issues regarding the allocation concealment, sam-
ple size calculation and blinding of outcome assessors, 
among others. Likewise, Little et al.15 reported in 2015 that 
over 50% of articles published in the top ten Orthopaedics 
and Traumatology journals belonged to the fourth level of 
evidence in the Oxford Centre for Evidence-Based Medicine 
classification.
Integrative studies, such as systematic reviews, rely on 
electronic strategies to exhaustively identify CCTs in a vari-
ety of sources.16,17 However, electronic strategies are limited 
by several reasons. First, the term CCT was only indexed in 
major databases in the 1990s. Second, poor reporting of 
methods hampers the indexing process. Finally, articles pub-
lished in journals not indexed in any database simply cannot 
be retrieved. As a result, integrative studies may be limited 
by dissemination bias. Cochrane proposes a handsearching 
approach involving a page-by-page examination of all issues 
for a selected journal in order to identify potential studies 
that address the research question.18,19
Several studies have researched the gap between the elec-
tronic search findings and those provided by handsearch-
ing.18–21 Hopewell et al.18 in 2007 located 34 studies 
comparing the number of trials identified by handsearching 
versus those identified by electronic searches, finding that 
individual electronic databases only identified from 49% to 
67% of trials. In addition, they found that the retrieval rate 
for an electronic search was lower when the search was 
restricted to languages other than English (39% vs 62%). 
The impact of handsearching of clinical trials in Spanish has 
been assessed for topics such as gynaecology and obstet-
rics,22 dermatology23 and physiotherapy,24 among others, 
finding similar results.
Few Orthopaedics and Traumatology journals from Latin 
America and Spain are indexed in major databases. CCTs 
published in these journals cannot be exhaustively retrieved 
using electronic literature searches. In order to overcome this 
shortcoming, we aimed to identify CCTs published in 
Orthopaedics and Traumatology journals from Latin America 
and Spain. In addition, we assessed their methodological qual-
ity and developed an evidence map in order to obtain a clear 
picture of the distribution of the information in this field. 
Finally, this body of evidence was submitted to CENTRAL, 
the Cochrane Collaboration global repository of CCTs.
Methodology
We performed a systematic review following a common 
methodology previously reported in other publications22,24–26 
and published in our website (http://es.cochrane.org/hand-
searching-clinical-trials-project), as well as PRISMA guide-
lines for reporting.27,28 First, we identified and listed all 
journals in Orthopaedics and Traumatology through the 
Spanish Medical Index, the National Catalogue of Spanish 
Publications in Health Sciences Libraries C-17, Latindex, 
LILACS, SCIELO and MEDLINE/PubMed. The content of 
all eligible journals up to July 2017, including original arti-
cles, letters to the editor, abstracts and conference proceed-
ings, was included in our research. Handsearching may take 
place in four stages: (a) reading the document’s table of con-
tents; (b) locating keywords in the title of each article (rand-
omized, random, fortuitous, blind etc.); (c) reading the 
summary of each article; and (d) reading the materials and 
methods section. The process should be completed retro-
spectively (i.e. backwards from the last year of publication). 
If no CCTs were found in a period of 5 consecutive years, 
handsearching for the corresponding journal was stopped. 
Three researchers conducted this process and disagreements 
were solved by consensus.
After selection of potential CCTs, the three authors inde-
pendently considered the following eligibility criteria:
1. The study compared interventions in humans.
2. The study was conducted in a prospective way.
3. The study compared two or more interventions.
4. Allocations of interventions should be reported as 
randomized or quasi-randomized.
Once the CCTs were selected, authors collected qualita-
tive information including topic, population and sample size. 
In addition, we extracted research questions framed in a 
PICO (specifying four key components: population, inter-
vention, comparison and outcomes) format.
The Cochrane risk of bias (RoB) tool was applied to 
included trials by two researchers independently.29 We 
assessed the following domains as having a low, unclear or 
high RoB, as follows:
•• Generation of the allocation sequence. Low risk: if 
methods of randomization include, for example, a 
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random number table, computer-generated lists or 
similar methods. Unclear risk: if the trial is described 
as randomized, but no description of the methods 
used to allocate participants to treatment group was 
given. High risk: if methods of randomization include, 
for example, alternation, the use of case record num-
bers, dates of birth or day of the week and any proce-
dure that is entirely transparent before allocation, 
such as an open list of random numbers.29
•• Allocation concealment. Low risk: if the allocation of 
participants involved, for example, a central inde-
pendent unit, on-site locked computer, identically 
appearing numbered drug bottles or containers pre-
pared by an independent pharmacist or investigator, 
or sealed opaque envelopes. Unclear risk: if the 
method used to conceal the allocation was not 
described. High risk: if the allocation sequence was 
known to or could be deciphered by the investigators 
who assigned participants.29
•• Blinding of participants and providers of care. Low 
risk: no blinding or incomplete blinding, but the 
review authors judge that the outcome is not likely to 
be influenced by lack of blinding, or blinding of par-
ticipants and key study personnel ensured, and 
unlikely that the blinding could have been broken. 
Unclear risk: insufficient information to permit judge-
ment of low or high risk. High risk: no blinding or 
incomplete blinding, and the outcome is likely to be 
influenced by lack of blinding or blinding of key 
study participants and personnel attempted, but likely 
that the blinding could have been broken, and the out-
come is likely to be influenced by lack of blinding.29
•• Blinding of outcome assessors. Low risk: no blinding 
of outcome assessment, but the review authors judge 
that the outcome measurement is not likely to be 
influenced by lack of blinding, or blinding of outcome 
assessment ensured, and unlikely that the blinding 
could have been broken. Unclear risk: insufficient 
information to permit judgement of low or high risk. 
High risk: no blinding of outcome assessment and the 
outcome measurement is likely to be influenced by 
lack of blinding, or blinding of outcome assessment, 
but likely that the blinding could have been broken, 
and the outcome measurement is likely to be influ-
enced by lack of blinding.29
•• Incomplete outcome data. Low risk: no missing out-
come data, reasons for missing outcome data unlikely 
to be related to true outcome, missing outcome data 
balanced in numbers across intervention groups, with 
similar reasons for missing data across groups, the 
proportion of missing outcomes compared with 
observed event risk not enough to have a clinically 
relevant impact on the intervention effect estimate for 
dichotomous outcome data), or missing data have 
been imputed using appropriate methods. Unclear 
risk: insufficient information to permit judgement of 
low or high risk. High risk: reason for missing out-
come data likely to be related to true outcome, with 
either imbalance in numbers or reasons for missing 
data across intervention groups, the proportion of 
missing outcomes compared with observed event risk 
enough to induce clinically relevant bias in interven-
tion effect estimate, ‘as-treated’ analysis done with 
substantial departure of the intervention received 
from that assigned at randomization, or potentially 
inappropriate application of simple imputation. In 
addition, trials with a total attrition of more than 30% 
were considered as with high RoB for this domain.29
•• Selective outcome reporting. Low risk: if the trial pro-
tocol is available and all of the trial’s pre-specified (pri-
mary and secondary) outcomes that are of interest in 
the review have been reported in the pre-specified way, 
or the trial protocol is not available but it is clear that 
the published reports include all expected outcomes, 
including those that were pre-specified. Unclear risk: if 
there is insufficient information to permit judgement of 
low or high risk. High risk: if, for example, not all of 
the study’s pre-specified primary outcomes have been 
reported; one or more primary outcomes is reported 
using measurements, analysis methods or subsets of 
the data (e.g. subscales) that were not pre-specified.29
•• Other sources of bias. Low risk: if the study appears 
to be free of other sources of bias. Unclear risk: if 
there is insufficient information to assess whether an 
important RoB exists. High risk: if, for example, the 
trial has a potential source of bias related to the spe-
cific study design used or was stopped early due to 
some data-dependent process.29
We considered CCTs as ‘high risk’ or ‘unclear risk’ if at 
least one of the assessed domains had a high or unclear RoB 
judgement, respectively.
For descriptive purposes, we categorized the conclusions 
on the effectiveness of those assessed interventions reported 
in included CCTs into six categories:
•• ‘Inconclusive’: authors did not provide a clear conclu-
sion of this research, including insufficient statistical 
methods to compare the assessed groups.
•• ‘No effect conclusion’: evidence for no difference 
between intervention and comparator.
•• ‘Harmful conclusion’: the reporting of the conclu-
sions was clearly indicative of a harmful effect.
•• ‘Probably harmful conclusion’: insufficient results to 
draw firm conclusions despite the negative treatment 
effect.
•• ‘Probably beneficial conclusion’: insufficient results 
to draw firm conclusions despite the positive treat-
ment effect, mostly based in physiological/laboratory 
results.
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•• ‘Beneficial conclusion’: authors used a language 
clearly indicative of a beneficial effect, based on 
patient-reported outcomes.
These categories were assigned by two of the researchers 
and were checked by another one. A descriptive analysis of 
this information was performed using STATA 14.0 (College 
Station, TX, USA).
In addition, we mapped the main findings of the identified 
CCTs. To this effect, we created bubble plots according to 
the topic of the PICOs, where each bubble represented one 
CCT. This chart displays information in three dimensions: 
(a) the rating of conclusions in the x-axis, (b) the interven-
tions in the y-axis and (c) bubble size according to the num-
ber of patients included in each CCT.
Results
We identified 5631 studies published 29 Orthopaedics/
Traumatology journals between 1995 and 2017. A total of 
116 references from 11 journals from six countries 
(Argentina, Chile, Colombia, Cuba, Spain and Mexico) were 
reviewed in full text, and 57 (1%) were included after 
consideration of eligibility criteria (Supplemental files 1 and 
2; Figure 1).
Journals from Spain and Mexico published over 63% of 
trials identified. About 33% of trials were published in Acta 
Ortopédica Mexicana (19/57). Most of these trials (8/57) 
were published in 2015 (Supplemental file 1).
The median patient sample size was 60 (range = 30–300 
participants). Most CCTs involved a comparison between a 
single intervention and a control group (89.5%). In all, 27 
out of 57 studies did not find differences regarding benefits/
harms between the interventions assessed (47.4%). Seven 
CCTs (12.3%) found benefits, but these were based on non-
patient reported outcomes (such as hospital stay, biomechan-
ical angles or costs). About 22 studies (38.5%) found benefits 
with the use of an assessed intervention.
Regarding the topic of included studies, 22 trials assessed 
issues related to knee conditions (38.5%), followed by 9 on 
hip (15.7%), and 6 on trauma or spine (10.5% for both condi-
tions). Only one study (1.75%) involved paediatric popula-
tions. Knee issues assessed anterior cruciate ligament 
management, knee arthroscopy, knee replacement and patel-
lofemoral syndrome, among others. Hip issues assessed 
included intertrochanteric fracture management, hip arthro-
plasty and replacement. Only one study assessed antimicro-
bial prophylaxis regimens. The intervention most frequently 
assessed was fracture fixation (8/57; 14.0%), followed by 
surgical haemostasis (6/57; 10.5%). Likewise, the most fre-
quent patient-reported outcome assessed was pain (12.5%; 
32/255 outcomes reported), followed by pre- and post-oper-
ative complications and surgical time (7.0% and 3.9%, 
respectively). A full analysis of these trials, in terms of popu-
lation, intervention assessed and outcomes evaluated are 
available in Supplemental file 2.
Regarding the quality of trials, all trials were considered 
as unclear or high risk in at least one assessed domain (Figure 
2 and Supplemental file 3). All trials were judged as unclear 
in the selective reporting domain as the study protocol was 
not available for the reader. The second domain most affected 
was random sequence generation concealment (30 with 
unclear risk and 13 with high RoB). Only two trials had low 
RoB in all items related to selection bias.30,31 Blinding of par-
ticipants and personnel was the most affected domain of all 
assessed blindings (46 with unclear RoB and 2 with high 
RoB). Blinding of outcome assessment was judged as low 
risk for 12 trials (21%). Seven trials were judged as low risk 
in all assessed blindings.32–38 In total, 19 trials were consid-
ered as unclear or high risk of incomplete outcome data 
(34%). Only five studies (8.8%) reported whether there was 
financial support for the developing of the research. 
Likewise, seven trials (12.3%) reported the absence of con-
flicts of interest. No trials reported the use of CONSORT 
guidelines to improve the quality of reporting.
An evidence map was developed for the four major areas 
(i.e. knee, hip, trauma and spine), considering the quality of 
the evidence, the assessed intervention and the sample size 
Figure 1. Flow chart for identification of CCT – Orthopaedics 
and Traumatology journals in Spanish.
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by each study (Figures 3–6). For interventions in the knee, 
most of the trials were considered as unclear RoB (18 trials) 
and without effect (11 trials). Anaesthesia and analgesic 
management was the most frequently assessed interventions 
(five trials). Two CCTs based on laboratory/physiological 
findings reported benefits for arthroscopy and arthroplasty 
interventions. No CCTs on nerve block, drainage and ante-
rior cruciate ligament reconstruction showed benefits (Figure 
3). For interventions in the hip, one study with unclear RoB 
reported benefits in surgical haemostasis (tranexamic acid 
use). In addition, one trial reported potential hams with the 
use of gamma-3 nail plus distal locking, but it was assessed 
as high RoB. Other fields with reported benefits were frac-
ture fixation and arthroscopy, but with unclear or high RoB 
(Figure 4). For the spine area, only six trials were found, and 
two reported benefits with the intervention assessed (transfu-
sion procedures and percutaneous vertebroplasty), but with 
unclear RoB. The remaining trials did not report effects for 
fields such as spinal fusion, ligamentoplasty, epidural injec-
tion and ozone therapy (Figure 5). Finally, regarding trauma, 
most of the identified trials were high or unclear RoB. 
Interventions related to fracture fixation showed benefits in 
two cases: closed reduction plus stabilization with Norian 
SRS in distal radius fracture and use of HAP-200 coraline 
hydroxyapatite plus open reduction of closed tibial diaphy-
seal fractures. One trial related to nerve block did not find 
effect with the use of supraclavicular blocking in patients 
with upper limb injuries (Figure 6).
Discussion
Orthopaedics and Traumatology is one of the largest surgical 
fields, thus its relevance is increasing due to the growth of the 
incidence and prevalence of musculoskeletal conditions.39 To 
Figure 2. Risk of bias graph – Orthopaedics and Traumatology journals in Spanish.
Figure 3. Mapping of controlled clinical trials on knee; Y-axis: Assessed intervention; X-axis: rating of conclusions; bubble size: number 
of patient included in each CCT; bubble color: Risk of bias (RoB) assessment (Green= low RoB; Yellow= unclear RoB; Red= high RoB).
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face all the challenges related to the management of these 
patients, constant research in evidence-based interventions is 
still needed.39
CCTs are preferred to assess the effectiveness and safety 
of healthcare interventions, including surgical interven-
tions.40,41 In our review, we found 57 trials published over 
22 years related to the management of orthopaedics and trau-
matology issues (1995–2017), with an estimated rate of 
publication of 2.5 trials per year. An important number of 
these trials was judged as unclear or high RoB (96%) using 
the RoB tool developed by the Cochrane Collaboration. It is 
critical to improving the adherence of standardized guide-
lines, such as CONSORT, which help to assure the adequate 
assessment of RoB in clinical trials.42 We checked the 
authors’ instructions for the two journals with the highest 
number of CCTs identified in this review, and we noticed 
Figure 4. Mapping of controlled clinical trials on hip; Y-axis: Assessed intervention; X-axis: rating of conclusions; bubble size: number of 
patient included in each CCT; bubble color: Risk of bias (RoB) assessment (Green= low RoB; Yellow= unclear RoB; Red= high RoB).
Figure 5. Mapping of controlled clinical trials on spine; Y-axis: Assessed intervention; X-axis: rating of conclusions; bubble size: number 
of patient included in each CCT; bubble color: Risk of bias (RoB) assessment (Green= low RoB; Yellow= unclear RoB; Red= high RoB).
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that these guidelines are currently included as mandatory 
since 2012–2014.
Limitations in the methodological quality of clinical trials 
in surgery fields had been assessed before with similar 
results.14,15 Information about the basal characteristic of 
patients, the consistency in the reporting of primary and sec-
ondary outcomes and the clear report of missing data are 
essential to assess the validity of trials. Recently, Zhang et al.43 
evaluated a sample of 299 trials published in high-impact-
factor journals in terms of consistency between outcomes 
reported in protocols and those reported in final manuscripts. 
They found that 8.4% of assessed trials presented selective 
outcome reporting, including changes of primary outcomes, 
the omission of primary outcomes declared in the protocol as 
well as changes in timing for outcome measurement. In our 
review, we did not have the opportunity to access the protocols 
of CCTs identified due to none of them have reported a previ-
ously published protocol or a registration in a public trial data-
base. As such, we cannot draw any conclusions about selective 
outcome reporting in these CCTs.
A considerable number of trials had no-effect results. From 
our perspective, we consider that these trials could have been 
rejected by English-language journals with higher impact fac-
tors. At present, only two of the reviewed journals are cur-
rently indexed in MEDLINE: Revista Española de Cirugía 
Ortopédica y Traumatología and Acta Ortopedica Mexicana. 
Around 37% of trials published in Spanish for orthopaedics 
and traumatology would not have been identified without 
handsearching. It is important to remark that the use of varied 
sources not only reduces the RoB but also increases the time 
and resources required to reach a conclusion.16
As a limitation of our review, we were unable to obtain 
access in all the sources we considered to the full-text 
articles of five journals: three published in Latin America 
and two in Spain (Supplemental file 1). However, the num-
ber of potential trials missing could be minimal, taking into 
account the total frequency of trials found by our study. In 
addition, we were unable to identify CCTs on Orthopaedic 
and Traumatology conducted in Spain and Latin America but 
published in international journals. Presumably, this body of 
work can be of higher quality. We are currently completing a 
study aimed to identify these CCTs and to compare their 
main characteristics with those identified in this study. In 
addition, we summarized the overall RoB by study level in 
order to classify and describe the methodological quality of 
identified trials. Despite that the Cochrane Handbook for 
Systematic reviews of interventions does not recommend an 
overall summary of RoB for a study across outcomes,29 we 
adopt this approach taking into account the multiplicity of 
both interventions and outcomes retrieved in this review, and 
the consequent limitations to prioritize specific RoB domains 
in this heterogeneous setting.
In conclusion, the number of CCTs published in 
Orthopaedic and Traumatology journals in Spanish is low. In 
addition, these CCTs have serious methodological limita-
tions. Most of the CCTs identified in this study would not 
have been retrieved using an electronic search strategy; 
therefore, handsearching of CCTs is an invaluable aid to 
comprehensively identifying all available evidence. These 
studies are now available in CENTRAL for potential inclu-
sion in systematic reviews and other documents of 
synthesis.
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Figure 6. Mapping of controlled clinical trials on trauma; Y-axis: Assessed intervention; X-axis: rating of conclusions; bubble size: number 
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